Zhibo Liu Selected Research

Bradykinin B1 Receptor

1/2016	Radiolabeled B9958 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography: Effect of the Radiolabel-Chelator Complex on Biodistribution and Tumor Uptake.
8/2015	Imaging Bradykinin B1 Receptor with 68Ga-Labeled [des-Arg10]Kallidin Derivatives: Effect of the Linker on Biodistribution and Tumor Uptake.
4/2015	Comparative studies of three 68Ga-labeled [Des-Arg10]kallidin derivatives for imaging bradykinin B1 receptor expression with PET.
3/2015	(18)F-trifluoroborate derivatives of [des-arg(10)]kallidin for imaging bradykinin b1 receptor expression with positron emission tomography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhibo Liu Research Topics

Disease

48	Neoplasms (Cancer) 04/2022 - 01/2013
6	COVID-19 01/2021 - 01/2020
3	Neoplasm Metastasis (Metastasis) 12/2022 - 03/2016
3	Glioma (Gliomas) 03/2022 - 01/2018
3	Brain Neoplasms (Brain Tumor) 03/2022 - 02/2016
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2020
3	Infections 01/2021 - 06/2020
3	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2013
2	Pneumonia (Pneumonitis) 01/2021 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 09/2014
2	Inflammation (Inflammations) 01/2021 - 03/2015
2	Triple Negative Breast Neoplasms 01/2021 - 12/2019
2	Hypertension (High Blood Pressure) 10/2020 - 10/2020
2	Tuberous Sclerosis (Bourneville's Disease) 10/2019 - 10/2014
2	Carcinogenesis 10/2019 - 10/2014
1	Plasmacytoma 01/2022
1	Breast Neoplasms (Breast Cancer) 05/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Foreign-Body Reaction 01/2021

Drug/Important Bio-Agent (IBA)

7	BoronIBA 11/2021 - 02/2016
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2014
4	Pharmaceutical PreparationsIBA 10/2021 - 12/2018
4	Bradykinin B1 ReceptorIBA 01/2016 - 03/2015
3	ProdrugsIBA 01/2022 - 01/2021
3	Amino Acids FDA Link 09/2018 - 01/2018
3	Peptides (Polypeptides)IBA 02/2016 - 04/2015
3	Biomarkers (Surrogate Marker)IBA 01/2016 - 08/2015
2	Biological ProductsIBA 12/2022 - 12/2021
2	RadiopharmaceuticalsIBA 01/2022 - 01/2022
2	Radioisotopes (Radionuclides)IBA 01/2022 - 02/2018
2	Therapeutic UsesIBA 01/2022 - 01/2021
2	Long Noncoding RNAIBA 01/2022 - 10/2019
2	AlbuminsIBA 01/2022 - 01/2022
2	MicellesIBA 01/2021 - 12/2018
2	Calcium Sulfate (Alabaster)IBA 01/2021 - 11/2019
2	PolymersIBA 01/2021 - 12/2018
2	AntigensIBA 01/2021 - 01/2019
2	Antihypertensive Agents (Antihypertensives)IBA 10/2020 - 10/2020
2	Oxygen (Dioxygen)IBA 01/2020 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2020 - 08/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2019 - 02/2018
2	Glutamine (L-Glutamine)FDA Link 12/2019 - 09/2018
2	Amino Acid Transport Systems (Amino Acid Transporter)IBA 11/2019 - 01/2018
2	trans-sodium crocetinate (crocetin)IBA 10/2019 - 12/2013
2	Glutamic Acid (Glutamate)FDA Link 10/2019 - 01/2019
2	SolutionsIBA 12/2018 - 09/2018
2	Carbonic Anhydrase IXIBA 03/2016 - 09/2015
2	Acetazolamide (Diamox)FDA LinkGeneric 03/2016 - 09/2015
2	EnzymesIBA 03/2016 - 09/2015
2	Sirolimus (Rapamycin)FDA Link 09/2015 - 12/2013
2	Mechanistic Target of Rapamycin Complex 1IBA 09/2015 - 10/2014
2	BombesinIBA 04/2015 - 01/2013
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 10/2014 - 12/2013
1	Ammonium CompoundsIBA 01/2022
1	AminesIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	carfilzomibIBA 01/2022
1	68Ga-FAPIIBA 01/2022
1	OxidesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Liposomes (Liposome)IBA 01/2022
1	MetalsIBA 10/2021
1	FluoridesIBA 10/2021
1	AcidsIBA 01/2021
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2021
1	apatinibIBA 01/2021
1	CopperIBA 01/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	ceftazidime drug combination avibactamIBA 01/2021
1	bone waxIBA 01/2021
1	IonsIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Poloxamer (Poloxamer 407)IBA 01/2021
1	hydroxide ionIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Boron-10IBA 01/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	CamptothecinIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Hydroxyl RadicalIBA 01/2021
1	phosphorylethanolamine (phosphoethanolamine)IBA 12/2020
1	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 12/2020
1	polyethylene glycol 2000IBA 12/2020
1	Copper-64IBA 12/2020
1	rhodolIBA 11/2020
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2020
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 10/2020

Therapy/Procedure

9	Therapeutics 01/2022 - 12/2013
7	Boron Neutron Capture Therapy 04/2022 - 12/2018
6	Precision Medicine 01/2022 - 10/2018
4	Chemoradiotherapy 01/2022 - 01/2018
3	Radiotherapy 01/2022 - 12/2020
3	Immunotherapy 01/2022 - 10/2018
3	Drug Therapy (Chemotherapy) 01/2021 - 09/2014
2	Photochemotherapy (Photodynamic Therapy) 12/2019 - 02/2018
1	Neoadjuvant Therapy 05/2021
1	Radioimmunotherapy 01/2021
1	Intravenous Injections 01/2021